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a b s t r a c t
Background:Anaemia is common in critically ill patients, andhas a signiﬁcant negative impact onpatients’
recovery. Blood conservation strategies have been developed to reduce the incidence of iatrogenic
anaemic caused by sampling for diagnostic testing.
Objectives: Describe practice and local guidelines in adult, paediatric and neonatal Australian intensive
care units (ICUs) regarding blood sampling and conservation strategies.
Methods: Cross-sectional descriptive study, conducted July 2013 over oneweek in single adult, paediatric
andneonatal ICUs in Brisbane. Datawere collected ondiagnostic blood samples obtainedduring the study
period, including demographic and acuity data of patients. Institutional blood conservation practice and
guidelines were compared against seven evidence-based recommendations.
Results:A total of 940blood sampling episodes from96patientswere examined across three sites. Arterial
blood gas was the predominant reason for blood sampling in each unit, accounting for 82% of adult, 80%
of paediatric and 47% of neonatal samples taken (p<0.001). Adult patients had signiﬁcantlymoremedian
[IQR] samples per day in comparison to paediatrics and neonates (adults 5.0 [2.4]; paediatrics 2.3 [2.9];
neonatal 0.7 [2.7]), which signiﬁcantly increased median [IQR] blood sampling costs per day (adults
AUD$101.11 [54.71]; paediatrics AUD$41.55 [56.74]; neonatal AUD$8.13 [14.95]; p<0.001). The total
volume of samples per day (median [IQR]) was also highest in adults (adults 22.3mL [16.8]; paediatrics
5.0mL [1.0]; neonates 0.16mL [0.4]). There was little information about blood conservation strategies
in the local clinical practice guidelines, with the adult and neonatal sites including none of the seven
recommendations.
Conclusions: There was signiﬁcant variation in blood sampling practice and conservation strategies
between critical care settings.
healthcare costs.
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. Introduction
.1. Background
Anaemia is common in critically ill patients admitted to the
CU1–3 with almost 95% of patients having an abnormally low
aemoglobin level by ICU day three.3 The damaging effects of
naemia include increased risk of cardiac morbidity and mortal-
ty, as well as a generalised decrease in oxygen carrying capacity
o the organs and tissues.2 Critically ill patients are at particular
isk for adverse consequences fromanaemia given the cardiovascu-
ar, respiratory andmetabolic compromise frequently encountered
uring critical illness.1
The aetiology of anaemia during critical illness is multifactorial.
ts severity is inﬂuenced by frequent phlebotomy, sepsis, gastroin-
estinal bleeding, coagulation disorders, blood loss from vascular
rocedures, renal failure, nutritional deﬁciencies, bone marrow
uppression and impaired erythropoietin response.1,2,4 For at least
0 years medical literature has highlighted the importance of an
atrogenic contribution to the anaemia seen inhospitalisedpatients
ue to blood sampling, and its potential negative impact upon
ecovery.1,5–10
Blood samples from critically ill patients are routinely col-
ected via arterial and central venous access devices, by peripheral
enepuncture or heal/ﬁnger prick.5,11 Blood draws from intravas-
ular devices increase blood loss due to the need to ﬁrst withdraw
clearing or ‘discard’ volume from the device, to ensure the resul-
ant sample iswhole blood and not partiallymedication or infusion
uid. Monitoring of blood ﬂow, acid-base status, oxygen transport,
oagulation, visceral organ functionand thedevelopmentofhealth-
are associated infection are a few of many reasons for diagnostic
lood testings.6 Previous reports of blood removed from critically
ll adult patients for testing average between 41.5mL and 377mL
er day.1,2,6,12 The described daily average blood sampling vol-
mes varied depending upon the population studied, the length
f stay evaluated and themethodology of the study; with the high-
st volumes commonly occurring in the immediate post-operative
eriod.1,2,6,12
Just over a decade ago, seminal work by Vincent et al.,2 and
orwin et al.,3 described the challenges associated with blood
onservation practices throughout ICUs and the resulting over-
rescription of packed red blood cell (PRBC) transfusions. Current
vidence suggests that PRBC transfusions are associatedwith infec-
ious and inﬂammatory complications, signiﬁcant ﬁnancial costs,
orse clinical outcomes and transfusion errors.1,7 A recent Aus-
ralian retrospective cohort study13 described the annual total
ospital-associated cost of PRBC transfusions as AU$77 million;
ith the inpatient costs of those who received a blood transfusion
.83 times higher than those not transfused, after adjusting for con-
ounders. The use of PRBC remains a signiﬁcant ﬁnancial burden
n the Australian healthcare system.10 Because of these burdens
nd risks, theNational Health andMedical Research Council10 have
hampioned the development of clinical protocols across health-
are facilities to minimise and direct the correct use of blood
roducts and other supportive therapies.
While phlebotomy and blood testing to inform clinical deci-
ion making is vital, strategies have been developed to minimise
nnecessary iatrogenic blood loss. Clinical practice strategies and
echnologies available in Australia include closed-system samp-
ing enabling safe return of arterial and central line clearing
olumes to the patient, small-volume phlebotomy tubes, fre-
uent clinical evaluation of routine or repetitive testing, use of
oninvasive methods where possible (e.g. end tidal carbon diox-
de [ETCO2], oxygen saturations [SpO2]), bundled scheduling of
lood tests to minimise loss of ‘clearing’ volume, routine chart-
ng of cumulative daily phlebotomy blood loss, and point of careical Care 29 (2016) 90–95 91
bedside microanalysis.1,4,6,12 Randomised controlled studies and
clinical controlled trials have been undertaken surrounding the
efﬁcacy of individual conservation strategies to prevent and/or
treat the associated anaemia, including the use of small-volume
phlebotomy tubes,14 closed-system sampling enabling safe discard
return5,15–18 and a combined approach.4,19 Other strategies com-
monly advocated in clinical settings, such as point of care bedside
microanalysis, have less rigorous observational studies to support
their use.20–22 The evidence to support and encourage the use of
these blood conservation strategies in critical care settings has
not been summarised in international clinical practice guidelines
(CPG), such as the CPG developed for the prevention of catheter-
related bloodstream infection.23–25 Instead, clinicians are guided
by the provision of local CPGs, developed within the hospital or
ICU based on varied quality of evidence, often combining peer-
reviewed research, local tradition and expert opinion.26,27
Although phlebotomy amounts can be dramatically reduced by
the use of blood conservation strategies, research suggests they are
not widely practiced in all adult, paediatric and neonatal ICUs.1
Landmark studies2,3 describing the importance of blood conser-
vation strategies to prevent iatrogenic anaemia for critically ill
patients were published almost a decade ago. Our study aimwas to
investigate the blood conservation practice across ICUs in Australia
and their direct ﬁnancial consequences.
1.2. Objectives
There were three study objectives:
1. To describe current blood sampling practices in adult, paediatric
and neonatal ICUs;
2. To provide an estimate of direct pathology costs associated with
blood sampling practices in adult, paediatric and neonatal ICUs;
and
3. To compare local CPG and current practice regarding blood con-




A cross-sectional, descriptive study was completed over one
week in July 2013.
2.2. Participants and setting
Blood sampling practice was audited within three Queensland
ICUs: the adult ICU at the Royal Brisbane and Women’s Hospi-
tal (RBWH), Brisbane, Australia; the paediatric ICU at the Royal
Children’s Hospital (RCH), Brisbane, Australia; and the neonatal
ICU at the RBWH, Australia. Each of the ICUs are tertiary-referral
centres for the area. Data were collected on all inpatients in the
three ICUs on each of seven days over one week. There were no
other inclusion or exclusion criteria. University and hospital ethics
approval was gained for this study (HREC/13/QRCH/32 and GU:
NRS/21/13/HREC).
2.3. Blood sampling audit
2.3.1. Data collection and measurement
In order to describe blood sampling practice in the critical care
settings, the main outcomes collected were the amount, frequency
and type of blood sampling from all patients during the audit





























































settings was routine or medical doctor requested (adults 93%; pae-
diatrics 99%; neonates 90%, p<0.024). ABGsweremore often nurse
initiated in the adult (49%) and paediatric ICUs (53%), as opposed
to the neonatal ICU which were most commonly due to medical
Table 1







Age (y):a – 8.4 (3.9) 53.2 (19.1)
Gestational age (wks):a 30.5 (5.4) – –
Weight (g):a 1518 (1264) – –
APACHE II:a – – 16.1 (7.0)
PELOD2:a 6.9 (0.7) 3.5 (3.3) –
Study ICU LOS (h):a 129.7 (61.9) 74.1 (51.5) 64.1 (60.9)
Gender:
Male 18 (60%) 8 (50%) 30 (60%)
Primary diagnosis:
Respiratory 24 (80%) 3 (19%) 7 (14%)
Post-operative 0 4 (25%) 22 (44%)
Trauma 0 3 (19%) 6 (12%)
Other 6 (20%) 6 (37.5%) 15 (30%)
Ventilated during ICU admission: 28 (93%) 8 (50%) 30 (60%)
Continuous renal replacement
therapy during ICU admission:
0 1 (7%) 2 (4%)
Mode of ICU admission:
Emergency 29 (98%) 13 (81%) 20 (40%)
Booked 1 (2%) 3 (18.7%) 30 (60%)
ICU outcome at study completion:
Discharged 0 10 (62%) 32 (64%)2 A.J. Ullman et al. / Australia
ach nurse for every shift documented the amount and reason for
ach blood sampling episode. Demographic and clinical variables
or the patients were recorded to examine for association with the
ain outcomes. The variables included age, severity of illness, ICU
ength of stay, primary diagnosis, ventilation, renal replacement
herapy and ICU outcome. The data collected were based on the
utcomes and variables reported in previous studies.1–3 Severity
f critical illness was estimated using paediatric logistic organ dys-
unction 2 (PELOD2) score for neonates and paediatrics28 (score
ange 0–71) and acute physiology and chronic health evaluation
I (APACHE II) for adults29 (score range 0–79). Both are cumula-
ive scores based on clinical and biological measurements, with
igher scores indicating higher levels of critical illness and risk of
ortality.
All data were collected on locally adapted data collection tools
ut using the same variables. Locally based study coordinators
versawthedata collectionbybedsidenurses for theaudit periodat
ach study site. Clinicians were educated about the data collection
ool and research project by the study coordinator using one-
n-one and group session education. The study coordinator was
vailable at all times during the audit period, to support clinician
ompliance. Prior to the audit period, the tool and data collection
rocesswerepiloted for feasibility andutility at eachsite for a single
ay and amendments made accordingly. Costing of blood samp-
ing was based on the pricing in the Medicare Beneﬁt Schedule30
or arterial blood gas (ABG), capillary blood gas, full blood count,
rinary electrolytes, liver function tests, coagulation studies, cross
atch and c-reactive protein.
.4. Blood conservation CPG
Local hospital guidelines and ICU CPGs regarding blood
ampling and conservation were appraised for speciﬁc recom-
endations regarding rationale, process, frequency and volume of
ampling. Local hospital and ICU CPG were provided via the ICU
anager. These included local policies, procedural guidelines, pro-
ocols, manuals, nursing standards or work instructions related to
loodsamplingandconservation. Eachwere reviewedandassessed
or content and incorporation of seven evidence-based blood con-
ervation strategies which are recommended in peer-reviewed
iterature.1,4,6,12 These strategies were: frequent evaluation by cli-
icians of routine blood sampling orders, closed-system sampling,
mall-volume phlebotomy tubes, non-invasive monitoring, bun-
led scheduling of blood sampling, charting of cumulative daily
hlebotomy loss and point of care testing.1,4,6,12
.5. Statistical methods
Data were entered and analysed using PASW Statistics Version
1.0 (SPSS Inc., Chicago, IL, USA). Basic frequencies were calculated
or all variables and any extreme or obviously incorrect data were
e-checked for accuracy. Blood sampling practices were described
sing descriptive statistics. Continuous variableswere summarised
singmeanwith standarddeviation (SD) ormedianwith interquar-
ile range (IQR) depending on normality of distribution. Categorical
ata was summarised by frequencies and percentages. Pathology
ost associated with blood sample across ICUs were summarised
s median costs with IQR per patient per day and per patient per
dmission. These were described for ABGs and total pathology
osts (a composite of all pathology tests including ABG, capillary
lood gas, full blood count, urinary electrolytes, liver function tests,
oagulation studies, cross match and c-reactive protein). Poten-
ial associations between intensive care settings and frequency,
olume and pathology costs of blood sampling were assessed by
hi square, Mann–Whitney, Kruskal–Wallis, t-tests or analysis of
ariance (ANOVA).31 Statistical results of p<0.05 were consideredical Care 29 (2016) 90–95




A total of 940 samples from96 patientswere examined; 100% of
patients admitted during the study period. Individually, 655 sam-
ples were examined from 50 patients in the adult ICU, 145 samples
from 16 patients in the paediatric ICU and 140 samples from 30
patients in the neonatal ICU.
3.2. Descriptive data
Table 1 provides the demographic characteristics of the par-
ticipants. The majority of the participants in each ICU were
mechanically ventilated and admitted to the ICU for at least 50h
during the study period. As expected from a heterogeneous study
population, the participants had a variety of age, primary diagno-
sis, severity of critical illness and admission sources. The PELOD2
scores for the paediatric ICU and neonatal ICU populations indi-
cated low to moderate levels of organ dysfunction.28 The APACHE
II score for the adult ICU population indicated a moderate level of
dependency and risk of mortality.29
3.3. Blood sampling practice
The individual characteristics of the blood sampling practices
between the ICUs are outlined in Table 2. ABG were the major rea-
son for blood sampling in each ICU accounting for 82% for samples
in adults, 80% in paediatrics and 47% in neonates (p<0.001). There
was 492/945 (52.1%) missing data on the reason for blood samp-
ling.Ofdata received, themain reason forbloodsamplingacross ICUStill in ICU 20 (67%) 6 (37%) 17 (34%)
Died 10 (33%) 0 1 (2%)
a Mean (standard deviation); APACHE, acute physiology and chronic health eval-
uation; LOS, length of stay; PELOD, paediatric logistic organ dysfunction.
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Table 2
Blood sampling across the included intensive care units (n=940).
Neonatal ICU (n=140) Paediatric ICU (n=140) Adult ICU (n=655) p values
Blood test: n (%)
Arterial blood gas 66 (47%) 116 (80%) 543 (82%) <0.001
Full blood count 21 (15%) 38 (26%) 152 (23%) 0.015
Capillary gas 35 (25%) 0 0 N/A
Urea, electrolytes and liver function test 9 (6%) 36 (25%) 157 (24%) <0.001
Other 38 (27%) 55 (38%) 128 (20%) N/A
Reason for blood sampling: n (%)
Routine 45 (33.1%)a 39 (45.4%)b 113 (47.5%)c 0.024
Medical request 77 (56.6%) 43 (54.4%) 109 (45.8%)
Previous abnormal result 6 (4.4%) 4 (5.1%) 8 (3.4%)
Other 8 (5.9%) 0 8 (3.4%)
Reason for arterial blood gas: n (%)
Medical staff request 84 (95.4%)d 39 (37.5%)e 75 (13.4%)f <0.001
Nurse initiated 0 55 (52.9%) 271 (48.5%)
Routine 3 (3.4%) 1 (1.0%) 192 (35.4%)
Other 1 (1.1%) 9 (8.6%) 21 (3.7%)
Number of samples/patient/day:g 0.7 (0.4) 2.3 (2.9) 5.0 (2.4) 0.045
Volume of samples/patient/day:g 0.16 (0.4) 5.0 (1.0) 22.3 (16.8) <0.001
Line clearance method: n (%)
Return 140 (100%) 99 (68%) 0 <0.001
Discard 0 46 (32%) 655 (100%)

























CTotal blood volume for sampling/patient/day: 0.15 (0.4)
7 missing; b66 missing; c419 missing; d55 missing; e41 missing; f97 missing; gme
taff request (95.4%). Themedian number of samples and volumeof
amples per patient per day in each ICU was signiﬁcantly different
etween the ICU settings (p<0.045 and p<0.001 respectively).
.4. Pathology costs associated with blood sampling
Median pathology costs (2014 AUD, Queensland Pathology) per
CU type for processingABGswerebetweenAU$5.25 (neonatal ICU)
ndAU$55.51 (adult ICU)perpatientperday (Table3). Total pathol-
gy costs (all blood tests) were between AU$8.31 (neonatal ICU)
nd AU$101.11 (adult ICU) per patient per day (Kruskal–Wallis H
est, p<0.001). These costs do not include nursing staff time to take
lood tests nor for blood sampling equipment used in the ICU.
.5. Blood conservation strategies in local CPG and in practice
Each of the ICUs had a local CPG regarding blood sampling, but
ontent varied in the inclusion of evidence-based blood conserva-
ion strategies (see Table 4). The neonatal and adult ICUhad speciﬁc
rocedural guidelines for the use of arterial (adult and neonatal)
nd umbilical lines (neonatal only) and their sampling, but not
or sampling from other sources (e.g. CVADs or heel pricks). The
aediatric ICU used local “nursing standards” in combination with
he medical registrar staff manual. Only the paediatric ICU con-
ained any of the evidence-based recommendations in their local
PG, while all ICUs used non-invasivemonitoring and point of care
esting within their practice.
able 3
ost of blood sampling pathology processing across the included intensive care units in A
Neonatal ICU
(n=140)












Blood Sample costs per patient per day
Median (IQR)
$8.13
(14.95)9.30 (8.4) 37.7 (23.1) <0.001
nterquartile range).
4. Discussion
This study achieved its aim to describe blood sampling practice
across critical care settings, provide costings of tests and audit
local guidelines for sampling processes and evidence-based rec-
ommendations. Demographics of each population demonstrated a
representative and comparable level of critical illness. Proxymeas-
ures of critical illness (mechanical ventilation, gestational age and
weight, length of stay in ICU and outcome) indicated a potentially
critically ill population in each of the ICU sites, including the neona-
tal ICU.
Our study found a lower median volume of blood samples per
adult patient per day (38mL) compared to previous studies in adult
ICU populations (41.5–377mL per day).1,2,6,12 This may be due
to increased awareness surrounding the contribution and conse-
quences associated with blood sampling and iatrogenic anaemia,
as alerted in the landmark studies.2,3 Comparisons to previous pae-
diatric or neonatal ICU studies could not be made, due to a lack of
reported blood sampling values and research in this area.
Adult participants were sampled more frequently and using
greater volumes, than the paediatric and neonatal participants.
The reason for this variation was not adequately explained by
comparison of severity of illness, as would be expected to inform
treatment decision-making (e.g. electrolyte and blood product
requirements). Wewere not able to directly compare illness sever-
ity between the study populations since there is no validated
assessment or scoring tool to compare critical illness severity
across the three age-relatedpopulations.However, proxymeasures
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Table 4




clinicians of necessity for



















Care of the umbilical
catheter; Care of the
arterial catheter
No No No No No No No








No No Yes No No No No
In practice No No Yes Yes No No Yes











































aCare of the arterial
catheter
In practice No No
ncluding mechanical ventilation, emergency admission type, and
ength of stay were more common in the neonatal population, in
omparison to adults. Despite this, neonates had the lowest num-
er of blood sampling episodes, and volumes drawn per day. If
he patients’ clinical characteristics are not the cause of increased
lood sampling frequency and volume, the underlying decision-
aking by clinicians is unclear. It is plausible that blood sampling
ractice remains a matter of tradition, clinician preference or fear,
n comparison to a reﬂection of the best available evidence. Aware-
ess of maintaining ﬂuid balance and blood volume, is likely more
rominent in theminds of neonatal ICU practitioners, with the risk
f iatrogenic anaemia under-estimated in older children or adult
atients.
The lower daily blood sampling volume in the paediatric and
eonatal ICUs was partially explained by the routine use of small-
olume phlebotomy tubes. Previous research by Smoller and
olleagues14 compared the use of paediatric tubes with regular
lood collection tubes in the adult health care setting, ﬁnding a 42%
ecrease in blood loss with the smaller tubes, without adverse out-
omes or diagnostic inaccuracy. Within Queensland public health
acilities, the actual sample required and the pathology costs asso-
iated with processing of small or standard-volume phlebotomy
ubes is the same30 so it is unclear why these are not rolled out for
ll patient testing. The role for standard-volume phlebotomy tubes
n the critically ill environment, where patients are at high risk for
naemia and its sequelae, is questionable.
While none of the included ICUs used ‘closed’ (in-line) arterial
lood sampling systems, there was a variety in practice surround-
ng the discard of line clearance ﬂuid. The neonatal population
eported 100% of line clearance ﬂuid was reinfused, while in adults
00% of line clearance ﬂuid was discarded. There is little direct evi-
ence regarding the safety of reinfusing line clearance ﬂuid; and
esearch that is available is conﬂicting with outcomes depend-
nt upon the variety of additional technologies used (e.g. closed
ystems, needleless connectors).32–34 There are theoretical con-
erns regarding the reinfusing of line clearance ﬂuid and the risk
or hub contamination and thrombosis. There are some condi-
ions for which the reinfusion of this ﬂuid causes unacceptable risk
f complication (e.g. hyper-coagulopathy,35 arterial spasm). Fur-
her evidence is needed in order to facilitate clinicians making an
nformed decision surrounding use of these technologies.
The study limitations include the small sample size, but it pro-
ides a snapshot of blood sampling and conservation information
ithin these speciﬁc study centres. These resultsmay not be gener-
lisable to all ICUs, however the ICUs that participated in the study
re likely somewhat indicative of non-cardiac tertiary AustralianNo Yes No No Yes
neonatal, paediatric and adult ICUs. Blood sampling practice was
audited via self-report completed by the ICU nursing staff. This
may have resulted in inaccurate or under-reporting, including
the exaggeration of practice to be in accordance with perceived
best practice. Using self-report also resulted in some areas having
substantial amounts of missing data which may reduce gener-
alisability. The strengths of the study were the cross sectional
comparison of variable sites and the use of multiple data points
in order to describe blood conservation and sampling practice.
The study is the ﬁrst to document paediatric and neonatal blood
sampling values in order to inform and direct areas of practice
improvement.
This research suggests adult patients in particular, and to some
extent paediatrics could reduce the number of blood tests drawn.
The results demonstrated the immediate pathology-associated
direct costs of blood analysis; the accompanying disposable con-
sumable costs and additional healthcareworker labour to draw the
specimens also should be considered. If adult ICU pathology costs
were decreased to the described neonatal estimates, this equates
to a saving of >AUD$26million to Australian healthcare institu-
tions annually.36 Additionally, the cumulative effect and costs due
to iatrogenic anaemia in the critically ill are substantial and are
well documentedwithin adult ICU and healthcare institutions.2,3,13
If adult blood sampling volumes were reduced to the described
neonatal volumes, thiswould result inover6000 l lessbloodwasted
annually due to testing and sampling.36 The direct and indirect
costs associated with the processing, labour and consequences of
potentially redundant diagnostic tests is continuing to place a sig-
niﬁcant encumbrance on strained healthcare systems.
The local CPGs in the ICUs were primarily focussed on safety,
infection control andblood samplingprocess, rather thanproviding
strategies to optimise blood conservation. Many blood conser-
vation strategies were evidently being used within the critical
care settings. However their implementation was not necessarily
directed at the prevention of iatrogenic anaemia or the reduction in
unnecessary blood sampling. This includes the use of non-invasive
monitoring and point-of-care analysis. In comparison to the mul-
tiple, high proﬁle, international CPG focussing on the reduction of
healthcare-associated infections,23,25,37,38 little international effort
has been made at translating the evidence available to support the
reduction of iatrogenic anaemia to the critical care bedside.5. Conclusions
Iatrogenic anaemia is a signiﬁcant burden for critical care, and
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escribed current practice of blood sampling and blood conserva-
ion in three critical care units in Australia. It has described the
ariation between these critical care areas in sampling frequency
nd volume, which are not adequately supported by research. Crit-
cally ill adults appear to be at high risk for potentially unnecessary
lood sampling and testing, in comparison to the neonatal popula-
ion. The clinical practice guidelines in use at each of the study sites
ere not reﬂective of evidence-based practice and demonstrates
he low priority this area of clinical practice has been relegated.
ontinued vigilance and effort are needed to increase awareness
mong clinicians and support their efforts to identify and elimi-
ate sources of unnecessary blood loss, such as duplicate tests and
he continuance of routine tests past medical need.12
Ensuring minimisation of unnecessary blood loss from exces-
ive sampling by reducing frequency or volume is within the scope
f nursing practice. It is the responsibility of researchers to help
linicians examine practice and provide evidence to drive decision
aking processes. Further implementation projects and research
re needed to accelerate implementation of known effective blood
onservation strategies within critical care environments.
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